Dustri Online Services

Search Results

Books: 0	Journals: 1	Articles: 3

Case reports

Type I membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection

M. Chidambaram, C.E. Stigant, L.M. Sugar and G.V. Ramesh Prasad

###ENGLISH_ABSTRACT_LINK### ###FREE_ENGLISH_ARTICLE_DOWNLIAD_LINK###

Volume 57 (2002) p. 154 - 157

Letters to the Editor

Recurrence of type III membranoproliferative glomerulonephritis after renal transplantation

G.V. Ramesh Prasad, F. Shamy and J.S. Zaltzman

###ENGLISH_ABSTRACT_LINK### ###FREE_ENGLISH_ARTICLE_DOWNLIAD_LINK###

Volume 61 (2004) p. 80 - 80

Original

Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation

G.V. Ramesh Prasad, , M. Huang, F. Bandukwala, M.M. Nash, L. Rapi, T. Montada-Atin, G. Meliton and J.S. Zaltzman,

###ENGLISH_ABSTRACT_LINK### ###FREE_ENGLISH_ARTICLE_DOWNLIAD_LINK###

Volume 71 (2009) p. 140 - 146

Abstract

G.V. Ramesh Prasad¹, ², M. Huang², F. Bandukwala², M.M. Nash², L. Rapi², T. Montada-Atin², G. Meliton² and J.S. Zaltzman¹,²

¹Division of Nephrology, University of Toronto, and ²Renal Transplant Program, St. Michael’s Hospital, Toronto, ON, Canada
Aim: New-onset diabetes after renal transplantation (NODAT) adversely affects graft and patient survival. However, NODAT risk based on pre-transplant blood glucose (BG) levels has not been defined. Our goal was to identify the best pre-transplant testing method and cut-off values. Materials and methods: We performed a case-control analysis of non-diabetic recipients who received a live donor allograft with at least 6 months post-transplant survival. Pre-transplant glucose abnormalities were excluded through 75 g oral glucose tolerance testing (OGTT) and random BG (RBG) measurement. NODAT was defined based on 2003 Canadian Diabetes Association criteria. Multivariate logistic and Cox regression analysis was performed to determine independent predictor variables for NODAT. Receiver-operating-characteristic (ROC) curves were constructed to determine threshold BG values for diabetes risk. Results: 151 recipients met initial entry criteria. 12 had pre-transplant impaired fasting glucose and/or impaired glucose tolerance, among who 7 (58%) developed NODAT. In the remaining 139, 24 (17%) developed NODAT. NODAT risk exceeded 25% for those with pre-transplant RBG > 6.0 mmol/l and 50% if > 7.2 mmol/l. Pre-transplant RBG provided the highest AUC (0.69, p = 0.002) by ROC analysis. Increasing age (p = 0.025), acute rejection (p = 0.011), and RBG > 6.0 mmol/l (p = 0.001) were independent predictors of NODAT. Conclusion: Pre-transplant glucose testing is a specific marker for NODAT. Patients can be counseled of their incremental risk even within the normal BG range if the OGTT is normal.Correspondence to:
G. V. Ramesh Prasad, MBBS, MSc, FRCPC, FACP, Assistant Professor of Medicine, University of Toronto, Staff Nephrologist, St. Michael’s Hospital, 61 Queen Street East, 9th Floor, Toronto, ON M5C 2T2, Canada
Email: [email protected]

Warenkorb Übersicht

Warenkorb Übersicht
Typ	Anz	Rabatt	MwSt	Preis
Der Warenkorb ist leer

Ihr Warenkorb

Search Results

Warenkorb Übersicht

Senden Sie uns eine E-Mail